Bionomics Ebitda from 2010 to 2024

BNOX Stock  USD 0.30  0.02  7.14%   
Bionomics EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA will likely drop to about -10.3 M in 2024. During the period from 2010 to 2024, Bionomics EBITDA regression line of annual values had r-squared of  0.20 and arithmetic mean of (8,259,253). View All Fundamentals
 
EBITDA  
First Reported
1999-03-31
Previous Quarter
400.5 K
Current Value
-3.4 M
Quarterly Volatility
M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bionomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bionomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 412.7 K, Interest Expense of 19 K or Other Operating Expenses of 18.8 B, as well as many indicators such as Price To Sales Ratio of 152.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.56. Bionomics financial statements analysis is a perfect complement when working with Bionomics Valuation or Volatility modules.
  
Check out the analysis of Bionomics Correlation against competitors.

Latest Bionomics' Ebitda Growth Pattern

Below is the plot of the Ebitda of Bionomics Ltd ADR over the last few years. It is Bionomics' EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bionomics' overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Bionomics Ebitda Regression Statistics

Arithmetic Mean(8,259,253)
Geometric Mean6,535,569
Coefficient Of Variation(76.11)
Mean Deviation4,917,834
Median(9,836,995)
Standard Deviation6,285,947
Sample Variance39.5T
Range22.4M
R-Value(0.45)
Mean Square Error33.8T
R-Squared0.20
Significance0.09
Slope(635,858)
Total Sum of Squares553.2T

Bionomics Ebitda History

2024-10.3 M
2023-9.8 M
2022-17.9 M
2021-11.5 M
2020-7 M
2019-4.2 M
2018-7.9 M

About Bionomics Financial Statements

Bionomics investors use historical fundamental indicators, such as Bionomics' Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bionomics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA-9.8 M-10.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bionomics Stock Analysis

When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.